Bicara Therapeutics Inc. (BCAX)
NASDAQ: BCAX · Real-Time Price · USD
7.93
-1.20 (-13.14%)
At close: Nov 2, 2026, 4:00 PM EST
7.74
-0.19 (-2.38%)
After-hours: Nov 2, 2026, 6:32 PM EST
Bicara Therapeutics Employees
Bicara Therapeutics had 103 employees as of December 31, 2025. The number of employees increased by 48 or 87.27% compared to the previous year. That makes Bicara Therapeutics the 31,254th largest employer in the world and 4,003rd in the United States.
Employees
103
Change (1Y)
48
Growth (1Y)
87.27%
Revenue / Employee
n/a
Profits / Employee
-$1,799,641
Market Cap
524.75M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 103 | 48 | 87.27% |
| Dec 31, 2024 | 55 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Gyre Therapeutics | 625 |
| Valneva SE | 620 |
| Puma Biotechnology | 179 |
| Neurogene | 131 |
| Crescent Biopharma | 69 |
| Surrozen | 44 |
| Shattuck Labs | 40 |
| DiaMedica Therapeutics | 35 |
BCAX News
- 10 hours ago - Bicara Therapeutics to Report Third Quarter 2026 Financial Results and Business Updates on November 9, 2026, at 8:30 AM ET - GlobeNewsWire
- 4 days ago - Bicara Therapeutics downgraded to Sell at Goldman on lower ficera outlook - TheFly
- 4 days ago - Bicara Therapeutics downgraded to Sell from Neutral at Goldman Sachs - TheFly
- 4 days ago - Bicara Therapeutics price target lowered to $24 from $33 at Wedbush - TheFly
- 13 days ago - Bicara Therapeutics price target raised to $41 from $39 at Morgan Stanley - TheFly
- 4 weeks ago - Bicara Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 2 months ago - Bicara Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 2 months ago - BMO starts Bicara at Outperform, sees meaningful upside potential - TheFly